Literature DB >> 19922899

Angiogenic dysfunction in molar pregnancy.

David Kanter1, Marshall D Lindheimer, Eileen Wang, Romana G Borromeo, Elizabeth Bousfield, S Ananth Karumanchi, Isaac E Stillman.   

Abstract

OBJECTIVE: Molar pregnancy is associated with very early-onset preeclampsia. Since excessive circulating antiangiogenic factors may play a pathogenic role in preeclampsia, we hypothesized that molar placentas produce more antiangiogenic proteins than normal placentas. STUDY
DESIGN: This retrospective case-control study used a semiquantitative immunohistochemical technique to compare histologic sections of molar placentas to normal controls. Tissue slides were treated with 2 antisera: one recognized the antiangiogenic markers fms-like tyrosine kinase receptor 1 (Flt1) and its soluble form (sFlt1), while the other recognized vascular endothelial marker CD31. Stain intensity was graded from 1+ (strong focal staining) to 4+ (91-100% staining).
RESULTS: Molar placentas (n = 19) showed significantly more staining than controls (n = 16) for Flt/sFlt1 (P < .0001).
CONCLUSION: There was a significant difference in Flt1/sFlt1 immunostaining intensity when molar placentas were compared to controls. This supports a hypothesis that the phenotype of preeclampsia in molar pregnancy may result from trophoblasts overproducing at least 1 antiangiogenic protein. Copyright 2010 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19922899      PMCID: PMC2832058          DOI: 10.1016/j.ajog.2009.09.005

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  14 in total

Review 1.  Hydatidiform mole and triploidy: the role of genomic imprinting in placental development.

Authors:  Koen Devriendt
Journal:  Hum Reprod Update       Date:  2005-01-27       Impact factor: 15.610

Review 2.  Circulating angiogenic factors in the pathogenesis and prediction of preeclampsia.

Authors:  Chun Lam; Kee-Hak Lim; S Ananth Karumanchi
Journal:  Hypertension       Date:  2005-10-17       Impact factor: 10.190

3.  History of miscarriage and increased incidence of fetal aneuploidy in subsequent pregnancy.

Authors:  Katherine Bianco; Aaron B Caughey; Brian L Shaffer; Regina Davis; Mary E Norton
Journal:  Obstet Gynecol       Date:  2006-05       Impact factor: 7.661

4.  The changing clinical presentation of complete molar pregnancy.

Authors:  V Soto-Wright; M Bernstein; D P Goldstein; R S Berkowitz
Journal:  Obstet Gynecol       Date:  1995-11       Impact factor: 7.661

5.  Circulating angiogenic proteins in trisomy 13.

Authors:  Yuval Bdolah; Glenn E Palomaki; Yuval Yaron; Tali Bdolah-Abram; Marlene Goldman; Richard J Levine; Benjamin P Sachs; James E Haddow; S Ananth Karumanchi
Journal:  Am J Obstet Gynecol       Date:  2006-01       Impact factor: 8.661

6.  Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia.

Authors:  Sharon E Maynard; Jiang-Yong Min; Jaime Merchan; Kee-Hak Lim; Jianyi Li; Susanta Mondal; Towia A Libermann; James P Morgan; Frank W Sellke; Isaac E Stillman; Franklin H Epstein; Vikas P Sukhatme; S Ananth Karumanchi
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

7.  In vivo angiogenic activity and hypoxia induction of heterodimers of placenta growth factor/vascular endothelial growth factor.

Authors:  Y Cao; P Linden; D Shima; F Browne; J Folkman
Journal:  J Clin Invest       Date:  1996-12-01       Impact factor: 14.808

8.  Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia.

Authors:  Shakil Ahmad; Asif Ahmed
Journal:  Circ Res       Date:  2004-10-07       Impact factor: 17.367

9.  Elevated serum soluble fms-like tyrosine kinase 1 (sFlt1) level in women with hydatidiform mole.

Authors:  Kaori Koga; Yutaka Osuga; Toshiki Tajima; Yasushi Hirota; Toshio Igarashi; Tomoyuki Fujii; Tetsu Yano; Yuji Taketani
Journal:  Fertil Steril       Date:  2009-03-09       Impact factor: 7.329

10.  Working group report on high blood pressure in pregnancy.

Authors:  C Lenfant
Journal:  J Clin Hypertens (Greenwich)       Date:  2001 Mar-Apr       Impact factor: 3.738

View more
  14 in total

Review 1.  Genetic predisposition to preeclampsia is conferred by fetal DNA variants near FLT1, a gene involved in the regulation of angiogenesis.

Authors:  Kathryn J Gray; Richa Saxena; S Ananth Karumanchi
Journal:  Am J Obstet Gynecol       Date:  2017-11-11       Impact factor: 8.661

2.  Environmental contaminants and preeclampsia: a systematic literature review.

Authors:  Emma M Rosen; Mg Isabel Muñoz; Thomas McElrath; David E Cantonwine; Kelly K Ferguson
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2018-12-24       Impact factor: 6.393

3.  Preeclampsia and the Anti-Angiogenic State.

Authors:  Isha Agarwal; S Ananth Karumanchi
Journal:  Pregnancy Hypertens       Date:  2011-01-01       Impact factor: 2.899

Review 4.  The etiology of preeclampsia.

Authors:  Eunjung Jung; Roberto Romero; Lami Yeo; Nardhy Gomez-Lopez; Piya Chaemsaithong; Adithep Jaovisidha; Francesca Gotsch; Offer Erez
Journal:  Am J Obstet Gynecol       Date:  2022-02       Impact factor: 8.661

5.  Toward a new taxonomy of obstetrical disease: improved performance of maternal blood biomarkers for the great obstetrical syndromes when classified according to placental pathology.

Authors:  Roberto Romero; Eunjung Jung; Tinnakorn Chaiworapongsa; Offer Erez; Dereje W Gudicha; Yeon Mee Kim; Jung-Sun Kim; Bomi Kim; Juan Pedro Kusanovic; Francesca Gotsch; Andreea B Taran; Bo Hyun Yoon; Sonia S Hassan; Chaur-Dong Hsu; Piya Chaemsaithong; Nardhy Gomez-Lopez; Lami Yeo; Chong Jai Kim; Adi L Tarca
Journal:  Am J Obstet Gynecol       Date:  2022-09-03       Impact factor: 10.693

6.  Evidence of an imbalance of angiogenic/antiangiogenic factors in massive perivillous fibrin deposition (maternal floor infarction): a placental lesion associated with recurrent miscarriage and fetal death.

Authors:  Amy E Whitten; Roberto Romero; Steven J Korzeniewski; Adi L Tarca; Alyse G Schwartz; Lami Yeo; Zhong Dong; Sonia S Hassan; Tinnakorn Chaiworapongsa
Journal:  Am J Obstet Gynecol       Date:  2013-01-17       Impact factor: 8.661

7.  Maternal plasma concentrations of angiogenic/antiangiogenic factors in the third trimester of pregnancy to identify the patient at risk for stillbirth at or near term and severe late preeclampsia.

Authors:  Tinnakorn Chaiworapongsa; Roberto Romero; Steven J Korzeniewski; Juan Pedro Kusanovic; Eleazar Soto; Jennifer Lam; Zhong Dong; Nandor G Than; Lami Yeo; Edgar Hernandez-Andrade; Agustín Conde-Agudelo; Sonia S Hassan
Journal:  Am J Obstet Gynecol       Date:  2013-01-17       Impact factor: 8.661

Review 8.  Angiogenic factors and preeclampsia.

Authors:  Sharon E Maynard; S Ananth Karumanchi
Journal:  Semin Nephrol       Date:  2011-01       Impact factor: 5.299

Review 9.  New developments in the pathogenesis of preeclampsia.

Authors:  Mihran V Naljayan; S Ananth Karumanchi
Journal:  Adv Chronic Kidney Dis       Date:  2013-05       Impact factor: 3.620

10.  Comparative gene expression profiling of placentas from patients with severe pre-eclampsia and unexplained fetal growth restriction.

Authors:  Haruki Nishizawa; Sayuri Ota; Machiko Suzuki; Takema Kato; Takao Sekiya; Hiroki Kurahashi; Yasuhiro Udagawa
Journal:  Reprod Biol Endocrinol       Date:  2011-08-02       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.